How a coronavirus study shed light on Epstein-Barr Virus reactivation in ME/CFS. Of all the opportunities the SARS-CoV-2 virus has inadvertently opened up for chronic fatigue syndrome (ME/CFS), this one might be the most creative thus far. This study highlights the...
This is the second in a series of blogs on the IACFS/ME 2022 International Conference on ME/CFS (and long COVID). The last one focused on David Systrom’s Keynote address. This one focused on an hour-long talk that kicked off the keynote session. Systrom’s...
“Millions of people continue to suffer from exhaustion, cognitive problems and other long-lasting symptoms after a coronavirus infection. The exact causes of the illness, known as long Covid, are not known. But new research offers clues, describing the toll the...
The question must have rattled through everyone’s mind at some point. Why me and not you? Why did you get over that cold while I never did? It’s one of the great questions in the chronic fatigue syndrome (field). Stabs have been taken at it before –...
University of Utah researchers hoped their new assay might uncover a new way to treat EBV infections – but they were shocked at what it turned up. How could a 50 year old kidney drug called Spironolactone have anything to do with EBV? Four years later they...
Almost all of us carry the Epstein-Barr virus (EBV) Some of us were introduced to it (and ME/CFS) during adolescence or later when we came down with infectious mononucleosis. Others have carried it in our bodies since childhood. EBV is one of the few viruses our...
